HGNC Family | Minor histocompatibility antigens, Glycosyltransferases |
Name | UDP glucuronosyltransferase 2 family, polypeptide B17 |
Description | This gene encodes a member of the uridine diphosphoglucuronosyltransferase protein family. The encoded enzyme catalyzes the transfer of glucuronic acid from uridine diphosphoglucuronic acid to a diverse array of substrates including steroid hormones and lipid-soluble drugs. This process, known as glucuronidation, is an intermediate step in the metabolism of steroids. Copy number variation in this gene is associated with susceptibility to osteoporosis.[provided by RefSeq, Apr 2010] |
Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nUGT2B17 is a phase II conjugating enzyme that catalyzes the glucuronidation of androgens – including testosterone, dihydrotestosterone (DHT) and their metabolites – thereby promoting their inactivation and elimination. The enzyme’s activity plays a central role in maintaining androgen homeostasis, particularly in androgen‐sensitive tissues such as the prostate. Variations in UGT2B17 such as deletion polymorphisms have been linked with differences in androgen disposition among ethnic groups and have implications for both prostate cancer risk and the interpretation of antidoping tests."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "7"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond androgen metabolism, UGT2B17 contributes to the detoxification of xenobiotics and metabolism of clinically used drugs. The enzyme glucuronidates carcinogenic tobacco metabolites—such as NNAL—and drugs like suberoylanilide hydroxamic acid (SAHA) and investigational compounds (e.g. MK-7246), with gene copy number variations and deletion polymorphisms greatly influencing its metabolic efficiency. Moreover, its expression is modulated by hormonal signals (through the androgen receptor, FXR, etc.) and post‐transcriptional regulators like microRNAs (for example, miR-376c), leading to marked interindividual and sex-related differences in glucuronidation capacity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "8", "end_ref": "16"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nClinically, genetic and epigenetic alterations of UGT2B17 have far‐reaching consequences. Its deletion and other copy number variations not only impact circulating androgen levels and urinary steroid profiles (with relevance for doping controls), but they are also associated with variable risks for hormone‐dependent cancers such as prostate, lung and breast cancer. In addition, promoter polymorphisms and microRNA‐mediated regulation further fine‐tune its expression, ultimately affecting drug pharmacokinetics and responsiveness. These findings underscore the enzyme’s dual roles both as a key regulator of steroid hormone metabolism and as a potential biomarker and therapeutic target in diverse disease states."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "17", "end_ref": "44"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Jenny Jakobsson, Lena Ekström, Nobuo Inotsume, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2005-1643"}], "href": "https://doi.org/10.1210/jc.2005-1643"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16332934"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16332934"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Tie-Lin Yang, Xiang-Ding Chen, Yan Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajhg.2008.10.006"}], "href": "https://doi.org/10.1016/j.ajhg.2008.10.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18992858"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18992858"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Jenny Jakobsson Schulze, Jonas Lundmark, Mats Garle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2008-0218"}], "href": "https://doi.org/10.1210/jc.2008-0218"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18334593"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18334593"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Yali Xue, Donglin Sun, Allan Daly, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Adaptive evolution of UGT2B17 copy-number variation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajhg.2008.08.004"}], "href": "https://doi.org/10.1016/j.ajhg.2008.08.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18760392"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18760392"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Minja J Pfeiffer, Frank P Smit, John P M Sedelaar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Steroidogenic enzymes and stem cell markers are upregulated during androgen deprivation in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2119/molmed.2010.00143"}], "href": "https://doi.org/10.2119/molmed.2010.00143"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21365123"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21365123"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Sarah Chouinard, Olivier Barbier, Alain Bélanger "}, {"type": "b", "children": [{"type": "t", "text": "UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M703370200"}], "href": "https://doi.org/10.1074/jbc.M703370200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17848572"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17848572"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Jong Park, Lan Chen, Luke Ratnashinge, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Epidemiol Biomarkers Prev (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1055-9965.EPI-06-0141"}], "href": "https://doi.org/10.1158/1055-9965.EPI-06-0141"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16896035"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16896035"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Steven A McCarroll, James E Bradner, Hannu Turpeinen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.490"}], "href": "https://doi.org/10.1038/ng.490"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19935662"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19935662"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Carla J Gallagher, Joshua E Muscat, Amy N Hicks, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: sex-specific association with urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronidation phenotype and risk for lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Epidemiol Biomarkers Prev (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1055-9965.EPI-06-0823"}], "href": "https://doi.org/10.1158/1055-9965.EPI-06-0823"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17416778"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17416778"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Gang Chen, Nino E Giambrone, Douglas F Dluzen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphisms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-09-4582"}], "href": "https://doi.org/10.1158/0008-5472.CAN-09-4582"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20876810"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20876810"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Bo-Ying Bao, Bin-Fay Chuang, Qianben Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Prostate (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/pros.20749"}], "href": "https://doi.org/10.1002/pros.20749"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18302198"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18302198"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "A-H Karypidis, M Olsson, S-O Andersson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenomics J (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.tpj.6500449"}], "href": "https://doi.org/10.1038/sj.tpj.6500449"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17387331"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17387331"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Philip Lazarus, Yan Zheng, E Aaron Runkle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genotype-phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/01.fpc.0000175596.52443.ef"}], "href": "https://doi.org/10.1097/01.fpc.0000175596.52443.ef"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16220109"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16220109"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Renee M Balliet, Gang Chen, Carla J Gallagher, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of UGTs active against SAHA and association between SAHA glucuronidation activity phenotype with UGT genotype."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-08-4143"}], "href": "https://doi.org/10.1158/0008-5472.CAN-08-4143"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19318555"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19318555"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Carla J Gallagher, Renee M Balliet, Dongxiao Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sex differences in UDP-glucuronosyltransferase 2B17 expression and activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Dispos (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/dmd.110.035345"}], "href": "https://doi.org/10.1124/dmd.110.035345"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20810538"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20810538"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Charlotte Swanson, Dan Mellström, Mattias Lorentzon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2007-0359"}], "href": "https://doi.org/10.1210/jc.2007-0359"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17698910"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17698910"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Dong G Hu, Luke A Selth, Gerard A Tarulli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-15-3372"}], "href": "https://doi.org/10.1158/0008-5472.CAN-15-3372"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27496708"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27496708"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Carla J Gallagher, Fred F Kadlubar, Joshua E Muscat, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Detect Prev (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cdp.2007.07.005"}], "href": "https://doi.org/10.1016/j.cdp.2007.07.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17935910"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17935910"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Sunita R Setlur, Chen X Chen, Ruhella R Hossain, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Epidemiol Biomarkers Prev (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1055-9965.EPI-09-1018"}], "href": "https://doi.org/10.1158/1055-9965.EPI-09-1018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20056642"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20056642"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Vincent Ménard, Olivier Eap, Mario Harvey, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mutat (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/humu.21054"}], "href": "https://doi.org/10.1002/humu.21054"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19572376"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19572376"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Sarah Chouinard, Georges Pelletier, Alain Bélanger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocr Res (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1081/erc-200044014"}], "href": "https://doi.org/10.1081/erc-200044014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15666817"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15666817"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Michaela Gruber, Judith Bellemare, Gregor Hoermann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2012-08-447359"}], "href": "https://doi.org/10.1182/blood-2012-08-447359"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23169782"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23169782"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Jenny Kaeding, Emmanuel Bouchaert, Julie Bélanger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20071136"}], "href": "https://doi.org/10.1042/BJ20071136"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17988216"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17988216"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Deepak Kumar Bhatt, Abdul Basit, Haeyoung Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hepatic Abundance and Activity of Androgen- and Drug-Metabolizing Enzyme UGT2B17 Are Associated with Genotype, Age, and Sex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Dispos (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/dmd.118.080952"}], "href": "https://doi.org/10.1124/dmd.118.080952"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29602798"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29602798"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Y-H Wang, M Trucksis, J J McElwee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "UGT2B17 genetic polymorphisms dramatically affect the pharmacokinetics of MK-7246 in healthy subjects in a first-in-human study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Pharmacol Ther (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/clpt.2012.20"}], "href": "https://doi.org/10.1038/clpt.2012.20"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22669291"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22669291"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Emmanuel Strahm, Jenny E Mullen, Nina Gårevik, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dose-dependent testosterone sensitivity of the steroidal passport and GC-C-IRMS analysis in relation to the UGT2B17 deletion polymorphism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Test Anal (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/dta.1841"}], "href": "https://doi.org/10.1002/dta.1841"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26198073"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26198073"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Sophie Pâquet, Ladan Fazli, Laurent Grosse, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2011-2064"}], "href": "https://doi.org/10.1210/jc.2011-2064"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22170718"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22170718"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Laurent Grosse, Sophie Pâquet, Patrick Caron, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-13-1462"}], "href": "https://doi.org/10.1158/0008-5472.CAN-13-1462"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24121496"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24121496"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Jong Y Park, Jean-Paul Tanner, Thomas A Sellers, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Urology (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.urology.2007.03.001"}], "href": "https://doi.org/10.1016/j.urology.2007.03.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17826523"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17826523"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Andy Z X Zhu, Qian Zhou, Lisa Sanderson Cox, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0070938"}], "href": "https://doi.org/10.1371/journal.pone.0070938"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23936477"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23936477"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Alicia Romero-Lorca, Apolonia Novillo, María Gaibar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0132269"}], "href": "https://doi.org/10.1371/journal.pone.0132269"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26176234"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26176234"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Jenny Jakobsson Schulze, Jonas Lundmark, Mats Garle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Substantial advantage of a combined Bayesian and genotyping approach in testosterone doping tests."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Steroids (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.steroids.2008.11.003"}], "href": "https://doi.org/10.1016/j.steroids.2008.11.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19056415"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19056415"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "E Strahm, P-E Sottas, C Schweizer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Steroid profiles of professional soccer players: an international comparative study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Sports Med (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/bjsm.2008.056242"}], "href": "https://doi.org/10.1136/bjsm.2008.056242"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19282302"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19282302"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Mats Olsson, Sara Lindström, Benjamin Häggkvist, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The UGT2B17 gene deletion is not associated with prostate cancer risk."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Prostate (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/pros.20700"}], "href": "https://doi.org/10.1002/pros.20700"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18247404"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18247404"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Masato Okano, Toshihiko Ueda, Yasunori Nishitani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "UDP-glucuronosyltransferase 2B17 genotyping in Japanese athletes and evaluation of the current sports drug testing for detecting testosterone misuse."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Test Anal (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/dta.1394"}], "href": "https://doi.org/10.1002/dta.1394"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22887913"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22887913"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Dhilushi D Wijayakumara, Dong Gui Hu, Robyn Meech, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Pharmacol Exp Ther (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/jpet.115.226118"}], "href": "https://doi.org/10.1124/jpet.115.226118"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26163549"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26163549"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Ebrahim Eskandari-Nasab, Mohammad Hashemi, Hamzeh Rezaei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofolate reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Rep (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11033-012-1938-8"}], "href": "https://doi.org/10.1007/s11033-012-1938-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23053953"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23053953"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Gang Chen, Nino E Giambrone, Philip Lazarus "}, {"type": "b", "children": [{"type": "t", "text": "Glucuronidation of trans-3'-hydroxycotinine by UGT2B17 and UGT2B10."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FPC.0b013e32834ff3a5"}], "href": "https://doi.org/10.1097/FPC.0b013e32834ff3a5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22228205"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22228205"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Guillaume Margaillan, Éric Lévesque, Chantal Guillemette "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic regulation of steroid inactivating UDP-glucuronosyltransferases by microRNAs in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Steroid Biochem Mol Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jsbmb.2015.09.021"}], "href": "https://doi.org/10.1016/j.jsbmb.2015.09.021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26385605"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26385605"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Lai Cai, Wei Huang, Kuo-Chen Chou "}, {"type": "b", "children": [{"type": "t", "text": "Prostate cancer with variants in CYP17 and UGT2B17 genes: a meta-analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Protein Pept Lett (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/092986612798472848"}], "href": "https://doi.org/10.2174/092986612798472848"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21919858"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21919858"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "A Juul, K Sørensen, L Aksglaede, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A common deletion in the uridine diphosphate glucuronyltransferase (UGT) 2B17 gene is a strong determinant of androgen excretion in healthy pubertal boys."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2008-1984"}], "href": "https://doi.org/10.1210/jc.2008-1984"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19088161"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19088161"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Jenny Kaeding, Julie Bélanger, Patrick Caron, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Calcitrol (1alpha,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Ther (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1535-7163.MCT-07-0455"}], "href": "https://doi.org/10.1158/1535-7163.MCT-07-0455"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18281521"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18281521"}]}, {"type": "r", "ref": 43, "children": [{"type": "t", "text": "Dong Gui Hu, Dione Gardner-Stephen, Gianluca Severi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel polymorphism in a forkhead box A1 (FOXA1) binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3α,17β-diol glucuronide."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharmacol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/mol.110.065953"}], "href": "https://doi.org/10.1124/mol.110.065953"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20628005"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20628005"}]}, {"type": "r", "ref": 44, "children": [{"type": "t", "text": "Lena Ekström, Maria Johansson, Anders Rane "}, {"type": "b", "children": [{"type": "t", "text": "Tissue distribution and relative gene expression of UDP-glucuronosyltransferases (2B7, 2B15, 2B17) in the human fetus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Dispos (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/dmd.112.049197"}], "href": "https://doi.org/10.1124/dmd.112.049197"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23223495"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23223495"}]}]}]}
|
Synonyms | BMND12, UDPGT2B17 |
Proteins | UDB17_HUMAN |
NCBI Gene ID | 7367 |
API | |
Download Associations | |
Predicted Functions |
![]() |
Co-expressed Genes |
![]() |
Expression in Tissues and Cell Lines |
![]() |
UGT2B17 has 4,678 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 92 datasets.
Click the + buttons to view associations for UGT2B17 from the datasets below.
If available, associations are ranked by standardized value
Dataset | Summary | |
---|---|---|
Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by UGT2B17 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of UGT2B17 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of UGT2B17 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of UGT2B17 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of UGT2B17 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of UGT2B17 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of UGT2B17 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of UGT2B17 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of UGT2B17 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of UGT2B17 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of UGT2B17 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
ChEA Transcription Factor Targets | transcription factors binding the promoter of UGT2B17 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of UGT2B17 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of UGT2B17 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing UGT2B17 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing UGT2B17 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with UGT2B17 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with UGT2B17 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
COSMIC Cell Line Gene Mutation Profiles | cell lines with UGT2B17 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
CTD Gene-Chemical Interactions | chemicals interacting with UGT2B17 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
CTD Gene-Disease Associations | diseases associated with UGT2B17 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
DepMap CRISPR Gene Dependency | cell lines with fitness changed by UGT2B17 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with UGT2B17 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with UGT2B17 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
DisGeNET Gene-Disease Associations | diseases associated with UGT2B17 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
DisGeNET Gene-Phenotype Associations | phenotypes associated with UGT2B17 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
DrugBank Drug Targets | interacting drugs for UGT2B17 protein from the curated DrugBank Drug Targets dataset. | |
ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at UGT2B17 gene from the ENCODE Histone Modification Site Profiles dataset. | |
ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of UGT2B17 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
ENCODE Transcription Factor Targets | transcription factors binding the promoter of UGT2B17 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
GAD Gene-Disease Associations | diseases associated with UGT2B17 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
GAD High Level Gene-Disease Associations | diseases associated with UGT2B17 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of UGT2B17 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
GeneRIF Biological Term Annotations | biological terms co-occuring with UGT2B17 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing UGT2B17 from the GeneSigDB Published Gene Signatures dataset. | |
GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of UGT2B17 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of UGT2B17 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of UGT2B17 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of UGT2B17 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of UGT2B17 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of UGT2B17 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
GO Biological Process Annotations 2015 | biological processes involving UGT2B17 gene from the curated GO Biological Process Annotations 2015 dataset. | |
GO Biological Process Annotations 2023 | biological processes involving UGT2B17 gene from the curated GO Biological Process Annotations 2023 dataset. | |
GO Biological Process Annotations 2025 | biological processes involving UGT2B17 gene from the curated GO Biological Process Annotations2025 dataset. | |
GO Cellular Component Annotations 2015 | cellular components containing UGT2B17 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
GO Cellular Component Annotations 2023 | cellular components containing UGT2B17 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
GO Cellular Component Annotations 2025 | cellular components containing UGT2B17 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
GO Molecular Function Annotations 2015 | molecular functions performed by UGT2B17 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
GO Molecular Function Annotations 2023 | molecular functions performed by UGT2B17 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
GO Molecular Function Annotations 2025 | molecular functions performed by UGT2B17 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
GTEx eQTL 2025 | SNPs regulating expression of UGT2B17 gene from the GTEx eQTL 2025 dataset. | |
GTEx Tissue Gene Expression Profiles | tissues with high or low expression of UGT2B17 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of UGT2B17 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of UGT2B17 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of UGT2B17 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
HMDB Metabolites of Enzymes | interacting metabolites for UGT2B17 protein from the curated HMDB Metabolites of Enzymes dataset. | |
HPA Tissue Gene Expression Profiles | tissues with high or low expression of UGT2B17 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
HPA Tissue Protein Expression Profiles | tissues with high or low expression of UGT2B17 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of UGT2B17 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
HuGE Navigator Gene-Phenotype Associations | phenotypes associated with UGT2B17 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
InterPro Predicted Protein Domain Annotations | protein domains predicted for UGT2B17 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of UGT2B17 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
KEGG Pathways | pathways involving UGT2B17 protein from the KEGG Pathways dataset. | |
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of UGT2B17 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of UGT2B17 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of UGT2B17 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of UGT2B17 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of UGT2B17 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
LOCATE Curated Protein Localization Annotations | cellular components containing UGT2B17 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain UGT2B17 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
MiRTarBase microRNA Targets | microRNAs targeting UGT2B17 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of UGT2B17 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
MW Enzyme Metabolite Associations | interacting metabolites for UGT2B17 protein from the MW Gene Metabolite Associations dataset. | |
OMIM Gene-Disease Associations | phenotypes associated with UGT2B17 gene from the curated OMIM Gene-Disease Associations dataset. | |
Pathway Commons Protein-Protein Interactions | interacting proteins for UGT2B17 from the Pathway Commons Protein-Protein Interactions dataset. | |
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of UGT2B17 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
PFOCR Pathway Figure Associations 2023 | pathways involving UGT2B17 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
PFOCR Pathway Figure Associations 2024 | pathways involving UGT2B17 protein from the Wikipathways PFOCR 2024 dataset. | |
Reactome Pathways 2014 | pathways involving UGT2B17 protein from the Reactome Pathways dataset. | |
Reactome Pathways 2024 | pathways involving UGT2B17 protein from the Reactome Pathways 2024 dataset. | |
RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of UGT2B17 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of UGT2B17 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of UGT2B17 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of UGT2B17 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of UGT2B17 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of UGT2B17 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of UGT2B17 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of UGT2B17 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with UGT2B17 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with UGT2B17 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
WikiPathways Pathways 2014 | pathways involving UGT2B17 protein from the Wikipathways Pathways 2014 dataset. | |
WikiPathways Pathways 2024 | pathways involving UGT2B17 protein from the WikiPathways Pathways 2024 dataset. | |